Taxotere Lawsuit Moves Forward

To expedite claims, the federal Judicial Panel on Multidistrict Litigation has transferred all pending Taxotere cases to the U.S. District Court for the Eastern District of Louisiana.

Sanofi-Aventis obtained the Food ad Drug Administration’s permission to sell Taxotere in 1996. Over the years, hundreds of victims filed suit, alleging that the manufacturer failed to adequately warn them about potential serious side effects. The plaintiffs also allege that, contrary to the manufacturer’s claims, this drug is only marginally more effective than some of its safer counterparts and Sanofi-Aventis used kickbacks and other illegal measures to promote and sell Taxotere.